1. Home
  2. IGIC vs ALVO Comparison

IGIC vs ALVO Comparison

Compare IGIC & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo International General Insurance Holdings Ltd.

IGIC

International General Insurance Holdings Ltd.

HOLD

Current Price

$25.52

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

Logo Alvotech

ALVO

Alvotech

HOLD

Current Price

$3.33

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IGIC
ALVO
Founded
2001
2013
Country
Jordan
Luxembourg
Employees
N/A
1460
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
IGIC
ALVO
Price
$25.52
$3.33
Analyst Decision
Buy
Buy
Analyst Count
1
4
Target Price
$28.00
$8.00
AVG Volume (30 Days)
45.5K
393.6K
Earning Date
05-05-2026
05-06-2026
Dividend Yield
5.25%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$0.13
$13.28
Revenue Next Year
$2.54
$18.63
P/E Ratio
$9.05
$18.20
Revenue Growth
N/A
N/A
52 Week Low
$20.82
$3.03
52 Week High
$27.43
$11.85

Technical Indicators

Market Signals
Indicator
IGIC
ALVO
Relative Strength Index (RSI) 48.55 46.12
Support Level $24.29 $3.10
Resistance Level $25.50 $3.83
Average True Range (ATR) 0.86 0.19
MACD -0.01 -0.00
Stochastic Oscillator 35.02 29.20

Price Performance

Historical Comparison
IGIC
ALVO

About IGIC International General Insurance Holdings Ltd.

International General Insurance Holdings Ltd is an international specialty insurance and reinsurance group. It underwrites a diversified portfolio of specialty risks including energy, property, construction and engineering, ports and terminals, general aviation, political violence, professional lines, financial institutions, marine, contingency and treaty reinsurance. The company's operating segments include Specialty Longtail, Specialty Short tail and Reinsurance. The majority of revenue is derived from the Specialty Short-tail segment, which comprises business lines with underwriting risks assumed in the form of property and specialty lines insurance and of short-term nature with respect to related claims.

About ALVO Alvotech

Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.

Share on Social Networks: